Literature DB >> 2185141

Cloning and characterization of the 2,3-oxidosqualene cyclase-coding gene of Candida albicans.

R Kelly1, S M Miller, M H Lai, D R Kirsch.   

Abstract

2,3-Oxidosqualene (OS) cyclase (OSC) catalyzes the conversion of OS to lanosterol, an essential step in the biosynthesis of sterols. The Candida albicans gene (ERG7) encoding OSC was cloned by complementation of a Saccharomyces cerevisiae OSC mutant (erg7). Two different Erg+ clones were isolated that contain a common overlapping region. The minimum region required for complementation was determined to be approx. 3.2 kb and a single 2.7-kb ERG7 transcript was detected. The cloned Candida ERG7 DNA complemented an additional nonconditional erg7 allele and a temperature-sensitive erg7 mutation. OSC activity was restored in the mutants as determined by [14C]acetate incorporation in vivo as well as incorporation in vitro in cell-free extracts using either [14C]isopentenyl pyrophosphate or [3H]OS as substrate. The level of OSC produced from expression of a single copy of the Candida ERG7 sequence was sufficient to allow growth of the S. cerevisiae erg7 mutants in the absence of exogenous ergosterol. These data support the contention that the Candida ERG7 sequence is the structural gene for OSC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185141     DOI: 10.1016/0378-1119(90)90299-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

1.  A zinc finger protein from Candida albicans is involved in sucrose utilization.

Authors:  R Kelly; K J Kwon-Chung
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

2.  Cloning, expression, and sequencing of squalene-hopene cyclase, a key enzyme in triterpenoid metabolism.

Authors:  D Ochs; C Kaletta; K D Entian; A Beck-Sickinger; K Poralla
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

Review 3.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.

Authors:  T C White
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 5.  Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae--a review.

Authors:  N D Lees; B Skaggs; D R Kirsch; M Bard
Journal:  Lipids       Date:  1995-03       Impact factor: 1.880

Review 6.  Genetics of Candida albicans.

Authors:  S Scherer; P T Magee
Journal:  Microbiol Rev       Date:  1990-09

7.  Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors.

Authors:  F S Buckner; J H Griffin; A J Wilson; W C Van Voorhis
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

8.  Inhibition of 2,3-oxidosqualene-lanosterol cyclase in Candida albicans by pyridinium ion-based inhibitors.

Authors:  R C Goldman; D Zakula; J O Capobianco; B A Sharpe; J H Griffin
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Isolation of an Arabidopsis thaliana gene encoding cycloartenol synthase by functional expression in a yeast mutant lacking lanosterol synthase by the use of a chromatographic screen.

Authors:  E J Corey; S P Matsuda; B Bartel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Isolation and characterization of the gene encoding 2,3-oxidosqualene-lanosterol cyclase from Saccharomyces cerevisiae.

Authors:  Z Shi; C J Buntel; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.